共 24 条
[11]
the multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer. Mylona, E,Kapranou, A,Mavrommatis, J,Markaki, S,KeramopoulosA,Nakopoulou, L. Acta Pathologica Microbiologica et Immunologica Scandinavica . 2005
[12]
MMP-2,MMP-9,VEGF and CA15.3in breast cancer. Quaranta M,Daniele A,Coviello M,et al. Anticancer Research . 2007
[13]
Expression of matrixmetalloproteinase(MMP-2)and extracellular matrixmetalloproteinases inducer(EMMPRIN)in benign and advancedbreast cancer tissue samples. Chandru H,Sharada AC,Manjunath S. Bioorganicheskaia khimiia . 2007
[14]
The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells. Nakopoulou,L,Giannopoulou,I,Lazaris,AC,Alexandrou,P,Tsirmpa,I,Markaki,S,Panayotopoulou,E,Keramopoulos,A. Acta Pathologica Microbiologica et Immunologica Scandinavica . 2003
[16]
Breast cancer brain metastases. Cheng X,Hung MC. Cancer and Metastasis Reviews . 2007
[17]
Zymog-raphy-method for quantita-tion of activity on gelatinase A(pro-MMP-2,72 kDa)and gela-tinase B(pro-MMP-9,92 kDa)in serum of patients with breastcancer. Sliwowska I,Kopczyski Z. Wiadomosci Lekarskie . 2007
[18]
A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmi-gration across the endothe-lial-basement membrane barrier. Kargozaran H,Yuan SY,Breslin JW,et al. Clinical and Experimental Metastasis . 2007
[19]
Prognostic significance of MMP-9and TIMP-1 serum and tissue expression in breast cancer. Wu ZS,,Wu Q,Yang JH,et al. International Journal of Cancer . 2008
[20]
High serumTIMP-1 correlates with poor prognosis in breast carcinomaa vali-dation study. Kuvaja P,Würtz S,Talvensaari Mattila A,et al. Cancer Biomark . 2007